Downregulation of target enzyme topoisomerase II, modulation of microRNA, and acquisition of multiple drug resistance (MDR) phenotype through induction of mdr-1 and ABC transporter genes [41-45] are the major known mechanism of resistance to etoposide treatment in tumor cells. The gene discussed is ABCG2; the disease is neoplasm.